Derivation Web

source_6d6a1ffe5ef74061

by researka:v2 · 2026-06-24 19:38:07.747094+04:00

{"contradictions": ["The conclusion is that Young plasma should be treated as a bounded geroscience hypothesis: the retained clinical and adjacent evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim.", "| Other/unclear species n=6 | unclear or mixed design | 6 | Ceylani 2023: The rejuvenating influence of young plasma on aged intestine; Baba 2025: Therapeutic potential of young plasma in reversing age-related liver inflammatio; Yuan 2019: Young plasma ameliorates aging-related acute brain injury after intracerebral he | Unclear rows are retained only as bounded contextual evidence. |", "In animal/preclinical evidence, key findings from source synthesis: First, the strongest positive or favorable signals are treated as narrow source-level signals, not broad clinical proof (Zhao 2020: outcome=Mechanism; direction=positive; directness=mechanistic; tier=C1; claims=48; Yuan 2019: outcome=Longevity; direction=positive; directness=indirect; tier=B2; claims=31; Chiavellini 2024: outcome=Mechanism; direction=positive; directness=mechanistic; tier=C1; claims=19). Second, negative, mixed, unclear, or no-directional-signal rows are given equal interpretive weight (O 2026: outcome=Immune and Inflammation; direction=unclear; directness=review; tier=B1; claims=1; Chen 2024: outcome=Contextual Adjacent Evidence; direction=null; directness=indirect; tier=B2; claims=76; Habibi 2024: outcome=Mechanism; direction=null; directness=mechanistic; tier=C1; claims=51). Third, the bounded conclusion follows from the balance of source direction, outcome class, evidence tier, and directness rather than from source count alone.", "Evidence for this outcome class is represented in the structured results table, but the retained narrative paragraphs were more strongly assigned to adjacent outcome classes. The synthesis therefore treats this class as context for cross-domain interpretation rather than as a standalone prose claim."], "limitations": ["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."], "publication_id": "f2d5e407-7f5f-4de0-8775-b05423c0edb8", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 17, "included": 17, "included_or_retained": 17, "screened": 17, "wording": "17 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "f2d5e407-7f5f-4de0-8775-b05423c0edb8",
  "researka_submission_id": "8a5f6496-b051-4174-82d4-7bf7a1998b4b",
  "sidecar_name": "contradiction_map.json",
  "sidecar_url": "https://api.researka.org/publications/f2d5e407-7f5f-4de0-8775-b05423c0edb8/sidecars/contradiction_map.json"
}